Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Jenscare Scientific's Ken Valve Receives NMPA Marketing Approval
CompanyMedical Device

Jenscare Scientific’s Ken Valve Receives NMPA Marketing Approval

March 25, 2025
SineuGene Therapeutics' SNUG01 Receives FDA Clearance for ALS Clinical Study
CompanyDrug

SineuGene Therapeutics’ SNUG01 Receives FDA Clearance for ALS Clinical Study

March 25, 2025
GSK's Nucala Accepted for EMA Review for COPD Treatment
CompanyDrug

GSK’s Nucala Accepted for EMA Review for COPD Treatment

March 25, 2025
Opella and JD Healthcare Collaborate to Enhance Fatty Liver Awareness in China
CompanyDeals

Opella and JD Healthcare Collaborate to Enhance Fatty Liver Awareness in China

March 25, 2025
Chongqing Zhifei Acquires 51% Stake in Chenan Bio for RMB593 Million
CompanyDeals

Chongqing Zhifei Acquires 51% Stake in Chenan Bio for RMB593 Million

March 25, 2025
Shanghai Ark Biopharmaceutical's AK0901 Meets Phase III Endpoints in ADHD Trial
CompanyDrug

Shanghai Ark Biopharmaceutical’s AK0901 Meets Phase III Endpoints in ADHD Trial

March 25, 2025
WuXi XDC Reports 90.8% Revenue Surge, Expanding in ADC Market
Company

WuXi XDC Reports 90.8% Revenue Surge, Expanding in ADC Market

March 25, 2025
Suzhou Xueji Biotech's XJ-MK-002 Gets FDA Orphan Drug Designation for CAMT
CompanyDrug

Suzhou Xueji Biotech’s XJ-MK-002 Gets FDA Orphan Drug Designation for CAMT

March 25, 2025
Beijing Sungen Biomedical's SGC001 Receives FDA Fast Track Designation for AMI Treatment
CompanyDrug

Beijing Sungen Biomedical’s SGC001 Receives FDA Fast Track Designation for AMI Treatment

March 25, 2025
CanSino Biologics Partners with Grand Life Sciences to Commercialize Tetanus Vaccine in Greater China
CompanyDeals

CanSino Biologics Partners with Grand Life Sciences to Commercialize Tetanus Vaccine in Greater China

March 25, 2025
AllianThera Biopharma Starts Global Phase I Trial for ATB102 in Inflammatory Bowel Diseases
CompanyDrug

AllianThera Biopharma Starts Global Phase I Trial for ATB102 in Inflammatory Bowel Diseases

March 24, 2025
Jiangsu Hengrui Pharmaceuticals' Ivarmacitinib Receives NMPA Approval for Ankylosing Spondylitis
CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Ivarmacitinib Receives NMPA Approval for Ankylosing Spondylitis

March 24, 2025
1 2 … 7 8 9 10 11 … 31 32
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up